T. Rowe Price Associates’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.57M Buy
68,993
+1,232
+2% +$28K ﹤0.01% 1761
2025
Q1
$2.06M Buy
67,761
+4,939
+8% +$150K ﹤0.01% 1599
2024
Q4
$2.49M Buy
62,822
+5,256
+9% +$208K ﹤0.01% 1545
2024
Q3
$3.65M Buy
57,566
+748
+1% +$47.4K ﹤0.01% 1396
2024
Q2
$3.84M Sell
56,818
-76,275
-57% -$5.15M ﹤0.01% 1301
2024
Q1
$10.5M Buy
133,093
+2,584
+2% +$205K ﹤0.01% 1095
2023
Q4
$10.1M Buy
130,509
+4,574
+4% +$356K ﹤0.01% 1088
2023
Q3
$8.86M Sell
125,935
-217,082
-63% -$15.3M ﹤0.01% 1086
2023
Q2
$27.3M Sell
343,017
-6,953
-2% -$554K ﹤0.01% 850
2023
Q1
$25.3M Sell
349,970
-151,635
-30% -$11M ﹤0.01% 853
2022
Q4
$41.3M Buy
501,605
+114,505
+30% +$9.43M 0.01% 712
2022
Q3
$30.3M Sell
387,100
-10,063,402
-96% -$787M 0.01% 782
2022
Q2
$707M Sell
10,450,502
-148,251
-1% -$10M 0.09% 229
2022
Q1
$695M Sell
10,598,753
-90,206
-0.8% -$5.91M 0.07% 272
2021
Q4
$649M Buy
10,688,959
+5,146
+0% +$312K 0.06% 302
2021
Q3
$681M Sell
10,683,813
-6,647
-0.1% -$424K 0.06% 296
2021
Q2
$671M Sell
10,690,460
-92,041
-0.9% -$5.78M 0.06% 294
2021
Q1
$616M Buy
10,782,501
+450,307
+4% +$25.7M 0.06% 301
2020
Q4
$519M Sell
10,332,194
-61,452
-0.6% -$3.09M 0.05% 320
2020
Q3
$306M Sell
10,393,646
-590,787
-5% -$17.4M 0.04% 391
2020
Q2
$276M Sell
10,984,433
-2,091,936
-16% -$52.5M 0.03% 403
2020
Q1
$240M Sell
13,076,369
-686,832
-5% -$12.6M 0.04% 368
2019
Q4
$457M Buy
13,763,201
+468,555
+4% +$15.6M 0.06% 319
2019
Q3
$413M Buy
13,294,646
+346,053
+3% +$10.8M 0.06% 314
2019
Q2
$453M Sell
12,948,593
-649,625
-5% -$22.7M 0.06% 297
2019
Q1
$399M Buy
13,598,218
+531,818
+4% +$15.6M 0.06% 305
2018
Q4
$336M Sell
13,066,400
-603,122
-4% -$15.5M 0.06% 304
2018
Q3
$481M Buy
13,669,522
+129,356
+1% +$4.55M 0.07% 277
2018
Q2
$554M Buy
13,540,166
+493,143
+4% +$20.2M 0.08% 234
2018
Q1
$511M Buy
13,047,023
+2,083,336
+19% +$81.6M 0.08% 248
2017
Q4
$358M Sell
10,963,687
-79,838
-0.7% -$2.61M 0.06% 331
2017
Q3
$527M Sell
11,043,525
-74,817
-0.7% -$3.57M 0.09% 241
2017
Q2
$549M Sell
11,118,342
-801,986
-7% -$39.6M 0.1% 228
2017
Q1
$520M Sell
11,920,328
-40,396
-0.3% -$1.76M 0.1% 235
2016
Q4
$396M Buy
11,960,724
+1,002,575
+9% +$33.2M 0.08% 277
2016
Q3
$543M Buy
10,958,149
+1,103,621
+11% +$54.7M 0.11% 212
2016
Q2
$546M Buy
9,854,528
+186,596
+2% +$10.3M 0.12% 207
2016
Q1
$533M Buy
9,667,932
+5,207,875
+117% +$287M 0.11% 206
2015
Q4
$279M Buy
4,460,057
+288,374
+7% +$18M 0.06% 323
2015
Q3
$276M Buy
4,171,683
+1,298,500
+45% +$86.1M 0.06% 333
2015
Q2
$225M Buy
2,873,183
+16,200
+0.6% +$1.27M 0.05% 416
2015
Q1
$205M Buy
2,856,983
+7,740
+0.3% +$554K 0.04% 438
2014
Q4
$174M Buy
2,849,243
+14,573
+0.5% +$892K 0.04% 467
2014
Q3
$137M Sell
2,834,670
-8,100
-0.3% -$393K 0.03% 514
2014
Q2
$129M Buy
2,842,770
+689,220
+32% +$31.4M 0.03% 558
2014
Q1
$97.2M Sell
2,153,550
-385,010
-15% -$17.4M 0.02% 641
2013
Q4
$120M Sell
2,538,560
-126,290
-5% -$5.98M 0.03% 562
2013
Q3
$105M Sell
2,664,850
-575,100
-18% -$22.7M 0.03% 577
2013
Q2
$107M Buy
+3,239,950
New +$107M 0.03% 552